Clinical Trial to Evaluate Safety and Efficacy of Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) With Mitomycin C Used During Surgery for Treatment of Locally Advanced Colorectal Carcinoma

Study ID
NCT02614534

Study type
Interventional

Study phase
Phase 3

Study status
Active, not recruiting

Trial Acronym

HIPECT4

Trial Summary

The purpose of this study is to determine whether Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma is effective in the treatment of locally advanced colorectal carcinoma.

More informations

Trial Starting Date

Nov 16,2015

Requirements

Gender All
Minimum age 18 Years
Maximum age 75 Years

Enrollement Limit

200